GSK3B and pancreatic neoplasm: Furthermore, inhibition of LZTS1 reduced the activity of AKT and its downstream target glycogen synthase kinase 3 β (GSK‐3β) in pancreatic cancer cells, while overexpressed LZTS1 led to upregulated activity of AKT and GSK‐3β.